Botulinum toxin injections for adults with overactive bladder syndrome

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Duthie, James ^a   Wilson, D I ^a   Herbison, G P ^a   Wilson, D ^a  

^a NONE

Author keywords

Administration, intravesical; Botulinum toxin type A administration dosage; Therapeutic use ; Botulinum toxins administration dosage; *Therapeutic use ; Neuromuscular agents administration dosage; *Therapeutic use

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; PLACEBO; RESINIFERATOXIN;

ANTIBIOTIC PROPHYLAXIS; BLADDER DISEASE; COCHRANE LIBRARY; CYSTITIS; CYSTOMETRY; DRUG DOSE COMPARISON; DRUG EFFICACY; FOLLOW UP; HUMAN; INTERMITTENT CATHETERIZATION; OVERACTIVE BLADDER; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYNDROME DELINEATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY FREQUENCY; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION; URODYNAMICS;

EID: 37249045979     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005493.pub2     Document Type: Review

References (26)

1. Ghei 2005 {published data only} Ghei M, Maraj B, Miller R, Nathan S, O'Sullivan C, Fowler CJ, et al.Effects of botulinum toxin B on refractory detrusor overactivity: a randomised, double blind, placebo controlled, crossover trial. The Journal of Urology 2005;174(5): 972-6.
2. Giannantoni 2004 {published data only} Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomised study. The Journal of Urology 2004;172(1):240-3. [MEDLINE: 19320].
3. Gousse 2005 {published data only} Gousse A, Tunuguntla H, Rodriguez D, Velasquez D. Dose-finding prospective randomised study to evaluate the efficacy and safety of botulinum-A toxin of refractory idiopathic overactive bladder (Abstract). Proceedings of the 35th Annual International Continence Society (ICS); 2005 Aug 28 - Sept 2; Montreal. 2005:Abstract 254.
4. Karsenty 2005 {published data only} Karsenty G, Boy S, Reitz A, et al.Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI)-a prospective randomized study to compare 30 vs. 10 injection sites (abstract). Neurourology and Urodynamics 2005;24(5/6):547-8. [MEDLINE: 20977].
5. Sahai 2005 {published data only} Sahai A, Khan M, Smith K, Dasgupta P. Botulinum toxin-A for patients with idiopathic detrusor overactivity: early results from a randomised, double-blind, placebo-controlled trial. Proceedings of the 35th Annual International Continence Society (ICS); 2005 Aug 28 - Sept 2; Montreal. 2005:Abstract 428.
6. Schurch 2005 {published data only} Schurch B, De Seze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, et al. Botulinum toxin type A is a safe and effective treatment for neuogenic urinary incontinence: results of a single treatment, randomised, placebo controlled 6-month study. The Journal of Urology 2005;174(1):196-200. [MEDLINE: 20654].
7. Thavaseelan 2005 {published data only} Thavaseelan J T, Burns-Cox N, Jordan K, Trewhella J. Efficacy of botulinum toxin type A (BOTOX) in the management of the neurogenic bladder: a prospective, randomised, double blind, dose comparative trial - interim overview of results. British Journal of Urology 2005;95 Suppl 1:4-5. [MEDLINE: 21155].
8. Truzzi 2004 {published data only} Truzzi J, Bruschini H, Simonetti R, Miguel S. What is the best dose for intravesical botulinum-A toxin injected in overactive bladder treatment? A prospective randomised preliminary study. Proceedings of the International Continence Society (34th Annual Meeting), and the International Urogynaecological Association; 2004 Aug 23-27; Paris. 2004:Abstract 520.
9. de Seze 2002 de Seze M, Petit H, Gallien P, de Seze MP, Joseph PA, Mazaux JM, Barat M. Botulinum A toxin and detrusor dyssenergia: A double-blind lidocaine-controlled study in 13 patients with spinal cord disease. European Urology 2002;42(1):56-62. [MEDLINE: 15931].
10. Dykstra 1990 Dykstra DD, Sidi AA. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Archives of Physical Medicine and Rehabilitation 1990;71(1):24-6. [MEDLINE: 384].
11. Giannantoni 2003 Giannantoni A, Di Stasi SM, Pizzirusso G, Mearini E, Bini V, Porena M. Intravesical resiniferatoxin versus botulinum-A toxin injections for the treatment of neurogenic detrusor overactivity (Abstract). Neurourology & Urodynamics 2003;22(5):497. [MEDLINE: 17103].
12. Giannantoni 2004B Giannantoni A, Mearini E, Di Stasi SM, Constantini E, Zucchi A, Mearini L, et al.New therapeutic options for refractory detrusor overactivity. Minerva Urologica e Nefrologica 2004;56(1):79-87. [MEDLINE: 20255].
13. Gousse 2005 B Gousse A, Tunuguntla H, Rodriguez D, Velasquez D. Validated instrument to assess pain tolerance during flexible endoscopy for intradetrusor botox-A injection. Proceedings of the 35th Annual International Continence Society (ICS); 2005 Aug 28 - Sept 2; Montreal 2005:Abstract 520. [MEDLINE: 21070].
14. Maria 1998 Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. New England Journal of Medicine 1998;338:217-20. [MEDLINE: 5285].
15. Maria 2003 Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 2003;62(2):259-64. [MEDLINE: 16639].
16. Ron 2001 Ron Y, Avni Y, Lukovetski A, Wardi J, Geva D, Birkenfeld S, Halpern Z. Botulinum toxin type-a in therapy of patients with anismus. Diseases of the Colon & Rectum 2001;44(12):1821-6. [MEDLINE: 12862].
17. Schurch 2004 Schurch B, Reitz A, Tenti G. Electromotive drug administration of lidocaine to anaesthetise the bladder before botulinum-A toxin injections into the detrusor. Spinal Cord 2004;42(6):338-41. [MEDLINE: 19336].
18. Schurch 2004 B Schurch B, de Seze M, Denys P, Chartier-Kastler E, Ismael S, Haab F, et al.Botulinum toxin A in neurogenic urinary incontinence: results from a multi-centre randomised, controlled trial (abstract). Neurourology & Urodynamics 2004;23(5/6):609-10. [MEDLINE: 19030].
19. Schurch 2005 B Schurch B, De Seze M, Denys P, Chartier-Kastler E, Haab F, Evereart K, et al.Subgroup analysis to determine impact of patient demographics on urodynamic response to focal administration of botulinum toxin A. Neurourology & Urodynamics 2005;24(5/6):545-6.
20. Eustice 2000 Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in adults. The Cochrane Database of Systematic Reviews 2000, Issue 2 Art. No.: CD002113. DOI:10.1002/14651858. CD002113.
21. Milsom 2001 Milsom I, Abrams P, Cardoza L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of overactive bladder and how are they managed? A population-based prevalence study. BJU International 2001;87(9):760-6.
22. Nabi 2006 Nabi G, Cody DJ, Ellis G, Hay-Smith J, Herbison P. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. The Cochrane Database of Systematic Reviews 2006, Issue 4 Art. No.: CD003781. DOI:10.1002/14651858.CD003781.pub2.
23. Ostaszkiewicz 2004a Ostaszkiewicz J, Johnston L, Roe B. Timed voiding for the management of urinary incontinence in adults. The Cochrane Database of Systematic Reviews 2004, Issue 1 Art. No.: CD002802. DOI:10.1002/14651858.CD002802.pub2.
24. Ostaszkiewicz 2004b Ostaszkiewicz J, Johnston L, Roe B. Habit retraining for the management of urinary incontinence in adults. The Cochrane Database of Systematic Reviews 2004, Issue 2 Art. No.: CD002801. DOI:10.1002/14651858.CD002801.pub2.
25. Stewart 2003 Stewart W, Van Rooyen J, Cundiff G, Abrams P, Herzog AR, Corey R, et al.Prevalence and burden of overactive bladder symdrome in the United States. World Journal of Urology 2003;20(6):327-36.
26. Wallace 2004 Wallace S, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults. The Cochrane Database of Systematic Reviews 2004, Issue 1 Art. No.: CD001308. DOI:10.1002/14651858. CD001308.pub2.